These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23140912)
21. The changing relationship between HbA1c and FPG according to different FPG ranges. Guan X; Zheng L; Sun G; Guo X; Li Y; Song H; Tian F; Sun Y J Endocrinol Invest; 2016 May; 39(5):523-8. PubMed ID: 26385729 [TBL] [Abstract][Full Text] [Related]
22. Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects. Robles-Osorio L; Aguilar-Salinas CA; Mehta R; Gómez-Pérez FJ; Rull JA Endocr Pract; 2007 Oct; 13(6):583-9. PubMed ID: 17954413 [TBL] [Abstract][Full Text] [Related]
23. Influence of the glycation gap on the diagnosis of type 2 diabetes. Rodriguez-Segade S; Rodriguez J; García-López JM; Casanueva FF; Coleman IC; Alonso de la Peña C; Camiña F Acta Diabetol; 2015 Jun; 52(3):453-9. PubMed ID: 25344767 [TBL] [Abstract][Full Text] [Related]
24. Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis. Kodama S; Horikawa C; Fujihara K; Hirasawa R; Yachi Y; Yoshizawa S; Tanaka S; Sone Y; Shimano H; Iida KT; Saito K; Sone H Diabetes Metab Res Rev; 2013 Nov; 29(8):680-92. PubMed ID: 23963843 [TBL] [Abstract][Full Text] [Related]
25. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians. Marini MA; Succurro E; Arturi F; Ruffo MF; Andreozzi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):561-6. PubMed ID: 21944738 [TBL] [Abstract][Full Text] [Related]
26. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test? Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264 [TBL] [Abstract][Full Text] [Related]
27. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology. Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616 [TBL] [Abstract][Full Text] [Related]
28. Clinical and Public Health Implications of 2019 Endocrine Society Guidelines for Diagnosis of Diabetes in Older Adults. Fang M; Echouffo-Tcheugui JB; Selvin E Diabetes Care; 2020 Jul; 43(7):1456-1461. PubMed ID: 32327419 [TBL] [Abstract][Full Text] [Related]
29. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. Norberg M; Eriksson JW; Lindahl B; Andersson C; Rolandsson O; Stenlund H; Weinehall L J Intern Med; 2006 Sep; 260(3):263-71. PubMed ID: 16918824 [TBL] [Abstract][Full Text] [Related]
30. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Temelkova-Kurktschiev TS; Koehler C; Henkel E; Leonhardt W; Fuecker K; Hanefeld M Diabetes Care; 2000 Dec; 23(12):1830-4. PubMed ID: 11128361 [TBL] [Abstract][Full Text] [Related]
31. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C. Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria. Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207 [TBL] [Abstract][Full Text] [Related]
33. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects. Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170 [TBL] [Abstract][Full Text] [Related]
34. Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults. Lee J; Lee YA; Kim JH; Lee SY; Shin CH; Yang SW Diabetes Metab J; 2019 Apr; 43(2):174-182. PubMed ID: 30398041 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values. Woerle HJ; Pimenta WP; Meyer C; Gosmanov NR; Szoke E; Szombathy T; Mitrakou A; Gerich JE Arch Intern Med; 2004 Aug 9-23; 164(15):1627-32. PubMed ID: 15302632 [TBL] [Abstract][Full Text] [Related]
36. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study. Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885 [TBL] [Abstract][Full Text] [Related]
37. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis. Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687 [TBL] [Abstract][Full Text] [Related]
38. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil. Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929 [TBL] [Abstract][Full Text] [Related]
39. Predictive Performance of Glycated Hemoglobin for Incident Diabetes Compared with Glucose Tolerance Test According to Central Obesity. Yoo S; Jung J; Kim H; Kim KY; Kim SK; Jung J; Hahm JR; Baek JH Endocrinol Metab (Seoul); 2020 Dec; 35(4):873-881. PubMed ID: 33397041 [TBL] [Abstract][Full Text] [Related]
40. HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose. Geberhiwot T; Haddon A; Labib M Ann Clin Biochem; 2005 May; 42(Pt 3):193-5. PubMed ID: 15949153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]